|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Catalano V, Labianca R, Beretta GD, Gatta
G, de Braud F and Van Cutsem E: Gastric cancer. Crit Rev Oncol
Hematol. 71:127–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zha L, Zhang J, Tang W, Zhang N, He M, Guo
Y and Wang Z: HMGA2 elicits EMT by activating the Wnt/β-catenin
pathway in gastric cancer. Dig Dis Sci. 58:724–733. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li N and Jiang D: Jumonji domain
containing 2C promotes cell migration and invasion through
modulating CUL4A expression in lung cancer. Biomed Pharmacother.
89:305–315. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su S, Lin X, Ding N, Zhang H, Zhang Q,
Ding Y, Hou X and Tian Y: Effects of PARP-1 inhibitor and ERK
inhibitor on epithelial mesenchymal transitions of the ovarian
cancer SKOV3 cells. Pharmacol Rep. 68:1225–1229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng S, Mao Q, Dong Y, Ren J, Su L, Liu
J, Liu Q, Zhou J, Ye X, Zheng S and Zhu N: GNB2L1 and its
O-GlcNAcylation regulates metastasis via modulating
epithelial-mesenchymal transition in the chemoresistance of gastric
cancer. PLos One. 12:e01826962017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang X, Zhou Y, Mehta KR, Danila DC,
Scolavino S, Johnson SR and Klibanski A: A pituitary-derived MEG3
isoform functions as a growth suppressor in tumor cells. J Clin
Endocrinol Metab. 88:5119–5126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Anwar SL, Krech T, Hasemeier B, Schipper
E, Schweitzer N, Vogel A, Kreipe H and Lehmann U: Loss of
imprinting and allelic switching at the DLK1-MEG3 locus in human
hepatocellular carcinoma. PloS One. 7:e494622012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ying L, Huang Y, Chen H, Wang Y, Xia L,
Chen Y, Liu Y and Qiu F: Downregulated MEG3 activates autophagy and
increases cell proliferation in bladder cancer. Mol Biosyst.
9:407–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun M, Xia R, Jin F, Xu T, Liu Z, De W and
Liu X: Downregulated long noncoding RNA MEG3 is associated with
poor prognosis and promotes cell proliferation in gastric cancer.
Tumour Biol. 35:1065–1073. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao T and Lin Z: MiR-21 is involved in
cervical squamous cell tumorigenesis and regulates CCL20. Biochim
Biophys Acta. 1822:248–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Morales Rivea D, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes andaffect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Geng YJ, Xie SL, Li Q, Ma J and Wang GY:
Large intervening non-coding RNA HOTAIR is associated with
hepatocellular carcinoma progression. J Int Med Res. 39:2119–2128.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding
Q, Weng H, Shu YJ, Liu TY, Jiang L, et al: MALAT1 promotes the
proliferation and metastasis of gallbladder cancer cells by
activating the ERK/MAPK pathway. Cancer Biol Ther. 15:806–814.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huber MA, Beug H and Wirth T:
Epithelial-mesenchymal transition: NF-kappaB takes center stage.
Cell Cycle. 3:1477–1480. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gloushankova NA, Rubtsova SN and Zhitnyak
IY: Cadherin-mediated cell-cell interactions in normal and cancer
cells. Tissue Barriers. 5:e13569002017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer: Trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ellis LM and Hicklin DJ: VEGF-targeted
therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer.
8:579–591. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Terashima M, Tange S, Ishimura A and
Suzuki T: MEG3 long noncoding RNA contributes to the epigenetic
regulation of epithelial-mesenchymal transition in lung cancer cell
lines. J Biol Chem. 292:82–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou X, Yuan P, Liu Q and Liu Z: LncRNA
MEG3 regulates imatinib resistance in chronic myeloid leukemia via
suppressing microRNA-21. Biomol Ther. 25:490–496. 2017. View Article : Google Scholar
|
|
29
|
Wu Z, He Y, Li D, Fang X, Shang T, Zhang H
and Zheng X: Long noncoding RNA MEG3 suppressed endothelial cell
proliferation and migration through regulating miR-21. Am J Transl
Res. 9:3326–3335. 2017.PubMed/NCBI
|
|
30
|
Zhang L, Liang X and Li Y: Long non-coding
RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and
inactivating PI3K/AKT pathway. Oncol Rep. 38:2408–2416. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang LJ, He CC, Sui X, Cai MJ, Zhou CY, Ma
JL, Wu L, Wang H, Han SX and Zhu Q: MiR-21 promotes intrahepatic
cholangiocarcinoma proliferation and growth in vitro and in vivo by
targeting PTPN14 and PTEN. Oncotarget. 6:5932–5946. 2015.PubMed/NCBI
|
